Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HIGH-LEVEL RESISTANCE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 380 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kyriakides, TC; Heimer, RR
      Development and application of a genotypic AZT resistance assay - Quantitative assessment of the resistance profile of clinical samples and the relative predictive ability of a resistance index

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Shulman, NS; Machekano, RA; Shafer, RW; Winters, MA; Zolopa, AR; Liou, SH; Hughes, M; Katzenstein, DA
      Genotypic correlates of a virologic response to stavudine after zidovudinemonotherapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Masquelier, B; Chaix, ML; Burgard, M; Lechenadec, J; Doussin, A; Simon, F; Cottalorda, J; Izopet, J; Tamalet, C; Douard, D; Fleury, H; Mayaux, MJ; Blanche, S; Rouzioux, C
      Zidovudine genotypic resistance in HIV-1-infected newborns in the French Perinatal Cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Lu, J; Kuritzkes, DR
      A novel recombinant marker virus assay for comparing the relative fitness of HIV-1 reverse transcriptase variants

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Duwe, S; Brunn, M; Altmann, D; Hamouda, O; Schmidt, B; Walter, H; Pauli, G; Kucherer, C
      Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Loveday, C
      Nucleoside reverse transcriptase inhibitor resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    7. Junco, MTT; Martin, MG; Toledo, MLP; Gomez, PL; Barrasa, JLM
      Identification and antibiotic resistance of faecal enterococci isolated from water samples

      INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH
    8. Garcia-Lerma, JG; Heneine, W
      Resistance of human immunodeficiency virus type 1 to reverse transcriptaseand protease inhibitors: genotypic and phenotypic testing

      JOURNAL OF CLINICAL VIROLOGY
    9. Miller, V; Larder, BA
      Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure

      ANTIVIRAL THERAPY
    10. Wainberg, MA; White, AJ
      Current insights into reverse transcriptase inhibitor-associated resistance

      ANTIVIRAL THERAPY
    11. Ross, L; Henry, K; Paar, D; Salvato, P; Shaefer, M; Fisher, R; Liao, QM; St Clair, M
      Thymidine-analog and multi-nucleoside resistance mutations are observed inboth zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens

      JOURNAL OF HUMAN VIROLOGY
    12. Tenover, FC
      Development and spread of bacterial resistance to antimicrobial agents: Anoverview

      CLINICAL INFECTIOUS DISEASES
    13. Nijhuis, M; Deeks, S; Boucher, C
      Implications of antiretroviral resistance on viral fitness

      CURRENT OPINION IN INFECTIOUS DISEASES
    14. Aarestrup, FM; Engberg, J
      Antimicrobial resistance of thermophilic Campylobacter

      VETERINARY RESEARCH
    15. Zouain, MG; Araj, GF
      Antimicrobial resistance of enterococci in Lebanon

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    16. Fitzgibbon, JE; Gaur, S; Walsman, SM; Janahi, M; Whitley-Williams, P; John, JF
      Emergence of drug resistance mutations in a group of HIV-infected childrentaking nelfinavir-containing regimens

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    17. Ross, L; Scarsella, A; Raffanti, S; Henry, K; Becker, S; Fisher, R; Liao, QM; Hirani, A; Graham, N; St Clair, M; Hernandez, J
      Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolatedfrom zidovudine-naive patients experiencing viremia on stavudine-containing regimens

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    18. Talon, D; Bertrand, X; Thouverez, M
      Risk factors and prevention of the acquisition and transmission of glycopeptide-resistant enterococci

      PATHOLOGIE BIOLOGIE
    19. Miranda, C; Lee, L; Kelly, C; Solorzano, F; Leanos, B; Munoz, O; Patterson, JE
      Antimicrobial resistance from enterococci in a pediatric hospital. Plasmids in Enterococcus faecalis isolates with high-level gentamicin and streptomycin resistance

      ARCHIVES OF MEDICAL RESEARCH
    20. Yang, SS; Cragg, GM; Newman, DJ; Bader, JP
      Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program

      JOURNAL OF NATURAL PRODUCTS
    21. Whalley, SA; Brown, D; Teo, CG; Dusheiko, GM; Saunders, NA
      Monitoring the emergence of hepatitis B virus polymerase gene variants during lamivudine therapy using the LightCycler

      JOURNAL OF CLINICAL MICROBIOLOGY
    22. Lennerstrand, J; Stammers, DK; Larder, BA
      Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    23. Masquelier, B; Race, E; Tamalet, C; Descamps, D; Izopet, J; Buffet-Janvresse, C; Ruffault, A; Mohammed, AS; Cottalorda, J; Schmuck, A; Calvez, V; Dam, E; Fleury, H; Brun-Vezinet, F
      Genotypic and penotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase(RT): Multicenter study of patients treated with RT inhibitors

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    24. Jeeninga, RE; Keulen, W; Boucher, C; Sanders, RW; Berkhout, B
      Evolution of AZT resistance in HIV-1: The 41-70 intermediate that is not observed in vivo has a replication defect

      VIROLOGY
    25. Stingele, K; Haas, J; Zimmermann, T; Stingele, R; Hubsch-Muller, C; Freitag, M; Storch-Hagenlocher, B; Hartmann, M; Wildemann, B
      Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy

      NEUROLOGY
    26. Sato, H; Tomita, Y; Ebisawa, K; Hachiya, A; Shibamura, K; Shiino, T; Yang, R; Tatsumi, M; Gushi, K; Umeyama, H; Oka, S; Takebe, Y; Nagai, Y
      Augmentation of human immunodeficiency virus type 1 subtype E (CRF01_AE) multiple-drug resistance by insertion of a foreign 11-amino-acid fragment into the reverse transcriptase

      JOURNAL OF VIROLOGY
    27. Perno, CF; Cozzi-Lepri, A; Balotta, C; Forbici, F; Violin, M; Bertoli, A; Facchi, G; Pezzotti, P; Cadeo, G; Tositti, G; Pasquinucci, S; Pauluzzi, S; Scalzini, A; Salassa, B; Vincenti, A; Phillips, AN; Dianzani, F; Appice, A; Angarano, G; Monno, L; Ippolito, G; Moroni, M; Monforte, AD
      Secondary mutations in the protease region of human immunodeficiency virusand virologic failure in drug-naive patients treated with protease inhibitor-based therapy

      JOURNAL OF INFECTIOUS DISEASES
    28. Argyris, EG; Vanderkooi, JM; Paterson, Y
      Mutagenesis of key residues identifies the connection subdomain of HIV-1 reverse transcriptase as the site of inhibition by heme

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    29. Tsakris, A; Pournaras, S; Maniatis, AN; Douboyas, J; Antoniadis, A
      Increasing prevalence of high-level gentamicin resistance among enterococci isolated in Greece

      CHEMOTHERAPY
    30. Stevenson, MAM; McBroom, DG
      In vitro characterization of FIV-pPPR, a pathogenic molecular clone of feline immunodeficiency virus, and two drug-resistant pol gene mutants

      AMERICAN JOURNAL OF VETERINARY RESEARCH
    31. Sluis-Cremer, N; Arion, D; Parniak, MA
      Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs)

      CELLULAR AND MOLECULAR LIFE SCIENCES
    32. Furman, PA; Painter, GR; Anderson, KS
      An analysis of the catalytic cycle of HIV-1 reverse transcriptase: Opportunities for chemotherapeutic intervention based on enzyme inhibition

      CURRENT PHARMACEUTICAL DESIGN
    33. Gotte, M; Wainberg, MA
      Biochemical mechanisms involved in overcoming HIV resistance to nucleosideinhibitors of reverse transcriptase

      DRUG RESISTANCE UPDATES
    34. Rando, RF; Nguyen-Ba, N
      Development of novel nucleoside analogues for use against drug resistant strains of HIV-1

      DRUG DISCOVERY TODAY
    35. Ross, L; Johnson, M; Ferris, RG; Short, SA; Boone, LR; Melby, TE; Lanier, R; Shaefer, M; St Clair, M
      Deletions in the beta 3-beta 4 hairpin loop of HIV-1 reverse transcriptaseare observed in HIV-1 isolated from subjects during long-term antiretroviral therapy

      JOURNAL OF HUMAN VIROLOGY
    36. O'Brien, WA
      Resistance against reverse transcriptase inhibitors

      CLINICAL INFECTIOUS DISEASES
    37. Alber, F; Carloni, P
      Ab initio molecular dynamics studies on HIV-1 reverse transcriptase triphosphate binding site: Implications for nucleoside-analog drug resistance

      PROTEIN SCIENCE
    38. Richard, N; Salomon, H; Oliveira, M; Rando, R; Mansour, T; Gu, ZX; Wainberg, MA
      Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    39. Jung, M; Lee, S; Kim, H; Kim, H
      Recent studies on natural products as anti-HIV agents

      CURRENT MEDICINAL CHEMISTRY
    40. Xu, HX; Wan, M; Dong, H; But, PPH; Foo, LY
      Inhibitory activity of flavonoids and tannins against HIV-1 protease

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    41. Gilbert, PB; Hanna, GJ; De Gruttola, V; Martinez-Picado, J; Kuritzkes, DR; Johnson, VA; Richman, DD; D'Aquila, RT
      Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    42. de Baar, MP; Janssens, W; de Ronde, A; Fransen, K; Colebunders, R; Kestens, L; van der Groen, G; Goudsmit, J
      Natural residues versus antiretroviral drug-selected mutations in HIV type1 group O reverse transcriptase and protease related to virological drug failure in vivo

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    43. Aarestrup, FM; Agerso, Y; Gerner-Smidt, P; Madsen, M; Jensen, LB
      Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    44. Weber, B; Ehlert, K; Diehl, A; Reichmann, P; Labischinski, H; Hakenbeck, R
      The fib locus in Streptococcus pneumoniae is required for peptidoglycan crosslinking and PBP-mediated beta-lactam resistance

      FEMS MICROBIOLOGY LETTERS
    45. Welles, SL; Pitt, J; Colgrove, R; McIntosh, K; Chung, PH; Colson, A; Lockman, S; Fowler, MG; Hanson, C; Landesman, S; Moye, J; Rich, KC; Zorrilla, C; Japour, AJ
      HIV-1 genotypic zidovudine drug resistance and the risk of maternal-infanttransmission in the Women and Infants Transmission Study

      AIDS
    46. Bertrand, X; Thouverez, M; Bailly, P; Cornette, C; Talon, D
      Clinical and molecular epidemiology of hospital Enterococcus faecium isolates in eastern France

      JOURNAL OF HOSPITAL INFECTION
    47. Briones, C; Mas, A; Gomez-Mariano, G; Altisent, C; Menedez-Arias, L; Soriano, V; Domingo, E
      Dynamics of dominance of a dipeptide insertion in reverse transcriptase ofHIV-1 from patients subjected to prolonged therapy

      VIRUS RESEARCH
    48. Omrani, AS; Pillay, D
      Multi-drug resistant HIV-1

      JOURNAL OF INFECTION
    49. Seta, T; Yokosuka, O; Imazeki, F; Tagawa, M; Saisho, H
      Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients

      JOURNAL OF MEDICAL VIROLOGY
    50. Richard, N; Salomon, H; Rando, R; Mansour, T; Bowlin, TL; Wainberg, MA
      Selection and characterization of human immunodeficiency virus type 1 variants resistant to the (+) and (-) enantiomers of 2 '-deoxy-3 '-oxa-4 '-thio-5-fluorocytidine

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    51. Petropoulos, CJ; Parkin, NT; Limoli, KL; Lie, YS; Wrin, T; Huang, W; Tian, H; Smith, D; Winslow, GA; Capon, DJ; Whitcomb, JM
      A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    52. Hertogs, K; Bloor, S; De Vroey, V; Van den Eynde, C; Dehertogh, P; Van Cauwenberge, A; Sturmer, M; Alcorn, T; Wegner, S; Van Houtte, M; Miller, V; Larder, BA
      A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    53. Lefort, A; Mainardi, JL; Tod, M; Lortholary, O
      Antienterococcal antibiotics

      MEDICAL CLINICS OF NORTH AMERICA
    54. Gotte, M; Arion, D; Parniak, MA; Wainberg, MA
      The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis

      JOURNAL OF VIROLOGY
    55. Quinones-Mateu, ME; Ball, SC; Marozsan, AJ; Torre, VS; Albright, JL; Vanham, G; van der Groen, G; Colebunders, RL; Arts, EJ
      A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression

      JOURNAL OF VIROLOGY
    56. Halvas, EK; Svarovskaia, ES; Freed, EO; Pathak, VK
      Wild-type and YMDD mutant murine leukemia virus reverse transcriptases areresistant to 2 ',3 '-dideoxy-3 '-thiacytidine

      JOURNAL OF VIROLOGY
    57. Sato, H; Tomita, Y; Shibamura, K; Shiino, T; Miyakuni, T; Takebe, Y
      Convergent evolution of reverse transcriptase (RT) genes of human immunodeficiency virus type 1 subtypes E and B following nucleoside analogue RT inhibitor therapies

      JOURNAL OF VIROLOGY
    58. Halvas, EK; Svarovskaia, ES; Pathak, VK
      Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity

      JOURNAL OF VIROLOGY
    59. Hanna, GJ; Johnson, VA; Kuritzkes, DR; Richman, DD; Brown, AJL; Savara, AV; Hazelwood, JD; D'Aquila, RT
      Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine

      JOURNAL OF INFECTIOUS DISEASES
    60. Harrigan, PR; Stone, C; Griffin, P; Najera, I; Bloor, S; Kemp, S; Tisdale, M; Larder, B
      Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy

      JOURNAL OF INFECTIOUS DISEASES
    61. Arion, D; Sluis-Cremer, N; Parniak, MA
      Mechanism by which phosphonoformic acid resistance mutations restore 3 '-azido-3 '-deoxythymidine (AZT) sensitivity to AZT-resistant HIV-1 reverse transcriptase

      JOURNAL OF BIOLOGICAL CHEMISTRY
    62. Arion, D; Parniak, MA
      HIV resistance to zidovudine: the role of pyrophosphorolysis

      DRUG RESISTANCE UPDATES
    63. Bacheler, LT
      Resistance to non-nucleoside inhibitors of HIV-I reverse transcriptase

      DRUG RESISTANCE UPDATES
    64. Richard, N; Quan, YD; Salomon, H; Hsu, M; Bedard, J; Harrigan, PR; Rando, R; Mansour, T; Bowlin, TL; Wainberg, MA
      Selection and characterization of HIV-1 variants resistant to the (+) and (-) enantiomers of 2 '-deoxy-3 '-oxa-4 '-thiocytidine (dOTC)

      ANTIVIRAL THERAPY
    65. Wainberg, MA; Miller, MD; Quan, YD; Salomon, H; Mulato, AS; Lamy, PD; Margot, NA; Anton, KE; Cherrington, JM
      In vitro selection and characterization of HIV-1 with reduced susceptibility to PMPA

      ANTIVIRAL THERAPY
    66. Lin, PF; Gonzalez, CJ; Griffith, B; Friedland, G; Calvez, V; Ferchal, F; Schinazi, RF; Shepp, DH; Ashraf, AB; Wainberg, MA; Soriano, V; Mellors, JW; Colonno, RJ
      Stavudine resistance: an update on susceptibility following prolonged therapy

      ANTIVIRAL THERAPY
    67. Hussain, M; Lok, ASF
      Mutations in the hepatitis B virus polymerase gene associated with antiviral treatment for hepatitis B

      JOURNAL OF VIRAL HEPATITIS
    68. Sugiura, W; Matsuda, M; Matsuda, Z; Abumi, H; Okano, A; Oishi, T; Moriya, K; Yamamoto, T; Fukutake, K; Mimaya, J; Ajisawa, A; Taki, M; Yamada, K; Nagai, Y
      Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors

      JOURNAL OF HUMAN VIROLOGY
    69. Sarafianos, SG; Das, K; Ding, JP; Boyer, PL; Hughes, SH; Arnold, E
      Touching the heart of HIV-1 drug resistance: the fingers close down on thedNTP at the polymerase active site

      CHEMISTRY & BIOLOGY
    70. Larder, BA; Stammers, DK
      Closing in on HIV drug resistance

      NATURE STRUCTURAL BIOLOGY
    71. Mori, H; Otake, T; Oishi, I; Kurimura, T
      Characterization of human immunodeficiency virus type 1 resistant to modified cyclodextrin sulphate (mCDS71) in vitro

      ANTIVIRAL CHEMISTRY & CHEMOTHERAPY
    72. Onyeji, CO; Bui, KQ; Nicolau, DP; Nightingale, CH; Bow, L; Quintiliani, R
      Influence of adjunctive interferon-gamma on treatment of gentamicin- and vancomycin-resistant Enterococcus faecalis infection in mice

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    73. Dressel, DC; Tornatore-Reuscher, MA; Boschman, CR; Stosor, V; Zembower, T; Postelnick, MJ; Noskin, GA; Peterson, LR
      Synergistic effect of gentamicin plus ampicillin on enterococci with differing sensitivity to gentamicin: A phenotypic assessment of NCCLS guidelines

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    74. Gatanaga, H; Oka, S; Ida, S; Wakabayashi, T; Shioda, T; Iwamoto, A
      Active HIV-1 redistribution and replication in the brain with HIV encephalitis

      ARCHIVES OF VIROLOGY
    75. Dienstag, JL; Schiff, ER; Mitchell, M; Casey, DE; Gitlin, N; Lissoos, T; Gelb, LD; Condreay, L; Crowther, L; Rubin, M; Brown, N
      Extended lamivudine retreatment for chronic hepatitis B: Maintenance of viral suppression after discontinuation of therapy

      HEPATOLOGY
    76. Alexander, CS; Dong, W; Schechter, MT; O'Shaughnessy, MV; Strathdee, SA; Mo, T; Montaner, JSG; Harrigan, PR
      Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users

      AIDS
    77. Puchhammer-Stockl, E; Schmied, B; Mandl, CW; Vetter, N; Heinz, FX
      Comparison of line probe assay (LIPA) and sequence analysis for detection of HIV-1 drug resistance

      JOURNAL OF MEDICAL VIROLOGY
    78. Izopet, J; Sailler, L; Sandres, K; Pasquier, C; Bonnet, E; Aquilina, C; Puel, J; Massip, P; Marchou, B
      Intermittent selection pressure with zidovudine plus zalcitabine treatmentreduces the emergence in vivo of zidovudine resistance HIV mutations

      JOURNAL OF MEDICAL VIROLOGY
    79. Kahn, J; Lagakos, S; Wulfsohn, M; Cherng, D; Miller, M; Cherrington, J; Hardy, D; Beall, G; Cooper, R; Murphy, R; Basgoz, N; Ng, E; Deeks, S; Winslow, D; Toole, JJ; Coakley, D
      Efficacy and safety of adefovir dipivoxil with antiretroviral therapy - A randomized controlled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    80. Larder, BA; Bloor, S; Kemp, SD; Hertogs, K; Desmet, RL; Miller, V; Sturmer, M; Staszewski, S; Ren, J; Stammers, DK; Stuart, DI; Pauwels, R
      A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    81. Asahi, Y; Takeuchi, Y; Ubukata, K
      Diversity of substitutions within or adjacent to conserved amino acid motifs of penicillin-binding protein 2X in cephalosporin-resistant Streptococcus pneumoniae isolates

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    82. Gavalda, J; Torres, C; Tenorio, C; Lopez, P; Zaragoza, M; Capdevila, JA; Almirante, B; Ruiz, F; Borrell, N; Gomis, X; Pigrau, C; Baquero, F; Pahissa, A
      Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    83. Cockerill, FR
      Genetic methods for assessing antimicrobial resistance

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    84. Lerma, JGG; Schinazi, RF; Juodawlkis, AS; Soriano, V; Lin, YL; Tatti, K; Rimland, D; Folks, TM; Heneine, W
      A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC)

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    85. Yoshimura, K; Feldman, R; Kodama, E; Kavlick, MF; Qiu, YL; Zemlicka, J; Mitsuya, H
      In vitro induction of human immunodeficiency virus type 1 variants resistant to phosphoralaninate prodrugs of Z-methylenecyclopropane nucleoside analogues

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    86. Sarafianos, SG; Das, K; Clark, AD; Ding, JP; Boyer, PL; Hughes, SH; Arnold, E
      Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves sterichindrance with beta-branched amino acids

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    87. Sharma, PL; Crumpacker, CS
      Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: a comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val

      JOURNAL OF VIROLOGY
    88. Powell, SK; Artlip, M; Kaloss, M; Brazinski, S; Lyons, R; McGarrity, GJ; Otto, E
      Efficacy of antiretroviral agents against murine replication-competent retrovirus infection in human cells

      JOURNAL OF VIROLOGY
    89. Miller, MD; Anton, KE; Mulato, AS; Lamy, PD; Cherrington, JM
      Human immunodeficiency virus type 1 expressing the lamivudine-associated M184V mutation in reverse transcriptase shows increased susceptibility to adefovir and decreased replication capability in vitro

      JOURNAL OF INFECTIOUS DISEASES
    90. Vandamme, AM; Van Laethem, K; De Clercq, E
      Managing resistance to anti-HIV drugs - An important consideration for effective disease management

      DRUGS
    91. Feng, JY; Anderson, KS
      Mechanistic studies examining the efficiency and fidelity of DNA synthesisby the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase

      BIOCHEMISTRY
    92. Balzarini, J
      Suppression of resistance to drugs targeted to human immunodeficiency virus reverse transcriptase by combination therapy

      BIOCHEMICAL PHARMACOLOGY
    93. Karmochkine, M; Descamps, D
      HIV resistance to antiviral therapy

      ANNALES DE MEDECINE INTERNE
    94. SAVES I; MASSON JM
      MECHANISMS OF RESISTANCE TO XENOBIOTICS IN HUMAN THERAPY

      Cellular and molecular life sciences
    95. ARTS EJ; QUINONESMATEU ME; ALBRIGHT JL
      MECHANISMS OF CLINICAL RESISTANCE BY HIV-I VARIANTS TO ZIDOVUDINE ANDTHE PARADOX OF REVERSE-TRANSCRIPTASE SENSITIVITY

      DRUG RESISTANCE UPDATES
    96. SCHMIT JC; MARTINEZPICADO J; RUIZ L; TURAL C; VANLAETHEM K; CABRERA C; IBANEZ A; PUIG T; WITVROUW M; DESMYTER J; DECLERCQ E; CLOTET B; VANDAMME AM
      EVOLUTION OF HIV DRUG-RESISTANCE IN ZIDOVUDINE ZALCITABINE-EXPERIENCED AND ZIDOVUDINE/DIDANOSINE-EXPERIENCED PATIENTS RECEIVING LAMIVUDINE-CONTAINING COMBINATION THERAPY/

      Antiviral therapy
    97. BRUUN L; KATZENSTEIN T; GERSTOFT J; PEDERSEN C; MATHIESEN LR; NIELSEN C
      DEVELOPMENT OF LYS TO ARG MUTATION AT CODON-70 OF THE REVERSE-TRANSCRIPTASE GENE OF HIV-1 DURING ZIDOVUDINE MONOTHERAPY AND ALTERNATING ZIDOVUDINE DIDANOSINE THERAPY/

      Antiviral therapy
    98. GASS RJA; SHUGARTS D; YOUNG R; ALLEN M; ROSANDICH M; KURITZKES DR
      EMERGENCE OF DUAL RESISTANCE TO ZIDOVUDINE AND LAMIVUDINE IN CLINICALHIV-1 ISOLATES FROM PATIENTS RECEIVING ZIDOVUDINE LAMIVUDINE COMBINATION THERAPY/

      Antiviral therapy
    99. MOYLE GJ; GAZZARD BG
      LAMIVUDINE IN THE MANAGEMENT OF ADULTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION

      Antiviral therapy
    100. PRINCIPI N; MARCHISIO P
      MEROPENEM COMPARED WITH CEFTAZIDIME IN THE EMPIRIC TREATMENT OF ACUTESEVERE INFECTIONS IN HOSPITALIZED CHILDREN

      Journal of chemotherapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 06:46:11